Epigenetic priming with oral decitabine/cedazuridine com-bined with nivolumab in unresectable or metastatic mucosal melanoma: Clinical and correlative findings from a phase Ib/II trial
Martin D. McCarter, Kasey L. Couts, Claire Muckle, Jessica S.W. Borgers et autres